Back to User profile » Dr Shunda Du

Papers published by Dr Shunda Du:


Original Research

Immunotherapy-Based Strategies versus Transcatheter Arterial Chemoembolization and the Impact of Treatment Duration in Hepatocellular Carcinoma with Microvascular Invasion: A Retrospective Multicenter Cohort Study

Chen X, Xing J, Zhang B, Peng W, Huang Z, Zhu T, Liu L, Liu X, Wan X, Mao Y, Chang X, Zhou K, Pan J, Hu D, Tan H, Zhang Y, Guan M, Du S

Journal of Hepatocellular Carcinoma 2025, 12:2379-2391

Published Date: 21 October 2025

Original Research

Adjuvant TACE Improves Prognosis After Resection in Dual-Phenotype Hepatocellular Carcinoma: A Propensity Score-Matched Study

Leng Z, Zhu T, Huang Z, Chen X, Lu Y, Zhang Y, Wan X, Yang X, Zhang L, Zhao H, Du S, Zhao Z, Zheng Y

Journal of Hepatocellular Carcinoma 2025, 12:2213-2224

Published Date: 30 September 2025

Original Research

Combined TACE with Targeted and Immunotherapy versus TACE Alone Improves DFS in HCC with MVI: A Multicenter Propensity Score Matching Study

Chen X, Wu X, Peng W, Liu L, Liu X, Wan X, Xu H, Zheng Y, Zhao H, Mao Y, Lu X, Sang X, Chang X, Zhou K, Pan J, Guan M, Hu D, Tan H, Zhang Y, Du S

Journal of Hepatocellular Carcinoma 2025, 12:561-577

Published Date: 19 March 2025

Original Research

In situ Detecting Lipids as Potential Biomarkers for the Diagnosis and Prognosis of Intrahepatic Cholangiocarcinoma

Li J, Chen Q, Guo L, Li J, Jin B, Wu X, Shi Y, Xu H, Zheng Y, Wang Y, Du S, Li Z, Lu X, Sang X, Mao Y

Cancer Management and Research 2022, 14:2903-2912

Published Date: 26 September 2022

Original Research

The Prognostic Value of Systemic Inflammation Response Index in Cholangiocarcinoma Patients

Jin B, Hu W, Su S, Xu H, Lu X, Sang X, Yang H, Mao Y, Du S

Cancer Management and Research 2021, 13:6263-6277

Published Date: 10 August 2021

Original Research

Prognostic Nomogram That Predicts Overall Survival of Patients with Distal Cholangiocarcinoma After Pancreatoduodenectomy

Chen Q, Li J, Jin B, Wu X, Shi Y, Xu H, Zheng Y, Wang Y, Du S, Lu X, Sang X, Mao Y

Cancer Management and Research 2020, 12:10303-10310

Published Date: 20 October 2020

Original Research

Preoperative Bilirubin-Adjusted Carbohydrate Antigen 19-9 as a Prognostic Factor for Extrahepatic Cholangiocarcinoma Patients at a Single Center

Li J, Chen Q, Jin B, Shi Y, Wu X, Xu H, Zheng Y, Wang Y, Du S, Lu X, Mao Y, Sang X

Cancer Management and Research 2020, 12:411-417

Published Date: 20 January 2020